The Pharmacy Guild has welcomed progress in the Sixth Community Pharmacy Agreement trial program following Sussan Ley’s confirmation today that the diabetes trial is set to begin.
More than 600 randomly-selected community pharmacies around Australia are being invited to register interest in the first trial of type 2 diabetes screening.
Confirming the go-ahead for this first trial today, the Minister for Health, Sussan Ley, said it represented a “transformative opportunity” for the pharmacy profession.
The objective of the Pharmacy Diabetes Screening Trial is to assess the comparative effectiveness and cost-effectiveness of alternative pharmacy-delivered models of opportunistic interventions for diabetes in an asymptomatic, previously undiagnosed population.
The proposed interventions involve three alternative models of screening the general population to facilitate increased risk identification, diagnosis and earlier interventions to prevent the development of diabetes and its complications.
The trial is a collaboration between the Pharmacy Guild of Australia, the University of Sydney and Deakin University.
The trial selects pharmacies randomly, stratified by metro, regional and rural areas – and invitations to express interest in participation will only be sought from those pharmacies randomly selected.
When registrations close, each area will be assessed by the project statistician who will randomly select from those pharmacies who have registered interest.
Following the registration of interest process, the trial will have a participation quota of 363 pharmacies across Australia. The trial is expected to commence in November 2016 – next month.
The 6CPA Pharmacy Trial Program was established to trial new and expanded programs that seek to improve clinical outcomes for consumers and/or extend the role of pharmacists in the delivery of primary healthcare services through community pharmacy.
The National President of the Pharmacy Guild, George Tambassis, says: “We welcome this progress with the Pharmacy Trial Program.
“As Australia’s most accessible health locations, community pharmacies are ideally placed for identifying individuals at high-risk of type 2 diabetes and screening them using recognised screening and risk assesment techniques.”